Shailendra K. Saxena

Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective

Shailendra K. Saxena, Swatantra Kumar, Saniya Ansari et al. · Journal of Medical Virology · 2021 · 306 citations

Vaccination, Spike Glycoprotein Sequences, Viral Evolution +13

Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)

Swatantra Kumar, Vimal K. Maurya, Anil K. Prasad et al. · VirusDisease · 2020 · 242 citations · Full text

Virus Structure, Novel Coronavirus, Immunology +6

Shiga Toxin, Shiga-like Toxin II Variant, and Ricin Are All Single-site RNA N-Glycosidases of 28 S RNA When Microinjected into Xenopus Oocytes

Shailendra K. Saxena, Alison D. O’Brien, E Ackerman · Journal of Biological Chemistry · 1989 · 238 citations · Full text

Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor

Vimal K. Maurya, Swatantra Kumar, Anil K. Prasad et al. · VirusDisease · 2020 · 219 citations · Full text

Role of the N Terminus in RNase A Homologues: Differences in Catalytic Activity, Ribonuclease Inhibitor Interaction and Cytotoxicity

Ester Boix, YouNeng Wu, Veena M. Vasandani et al. · Journal of Molecular Biology · 1996 · 184 citations

Ribonuclease Inhibitor Interaction, Biochemistry, Natural Sciences +7